$OXSQ
Oxford Square Capital Corp. Stock $oxsq

$oxsq Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024039266 Filed on May 03, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$11.45M	$10.68M	$6.491M
YoY Change	71.7%	64.5%	-34.21%
Cost Of Revenue	$2.984M	$2.949M	$5.475M
YoY Change	-47.13%	-46.14%	16.69%
Gross Profit	$8.461M	$7.729M	$7.467M
YoY Change	7.54%	3.51%	44.31%
Gross Profit Margin	73.93%	72.38%	115.04%
Selling, General & Admin	$739.2K	$1.191M	$976.0K
YoY Change	-38.51%	22.03%	5.67%
% of Gross Profit	8.74%	15.41%	13.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$3.724M	$3.814M	$6.451M
YoY Change	-45.62%	-40.88%	598.44%
Operating Profit	$4.738M	$3.915M	$1.016M
YoY Change	364.09%	285.37%	-76.1%
Interest Expense	-$2.463M	$1.961M	$3.085M
YoY Change	-179.76%	-36.44%	-124.79%
% of Operating Profit	-51.99%	50.09%	303.74%
Other Income/Expense, Net			$1.160M
YoY Change			-27.82%
Pretax Income	$5.259M	-$1.768M	$6.268M
YoY Change	-54.61%	-128.21%	-176.47%
Income Tax
% Of Pretax Income
Net Earnings	$5.259M	-$1.768M	$6.268M
YoY Change	-54.61%	-128.21%	-176.47%
Net Earnings / Revenue	45.95%	-16.56%	96.58%
Basic Earnings Per Share	$0.13	$0.11	$0.13
Diluted Earnings Per Share	$0.13	$0.11	$0.13
COMMON SHARES
Basic Shares Outstanding	59.72M shares	59.67M shares	49.87M shares
Diluted Shares Outstanding	60.65M shares	59.65M shares	49.86M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.01M	$20.91M	$10.76M
YoY Change	-30.25%	94.24%	-28.6%
Cash & Equivalents	$30.01M	$20.91M	$10.76M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$33.29M	$23.52M	$14.81M
YoY Change	-29.4%	58.81%	-19.31%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$252.1M	$250.9M	$319.7M
YoY Change	-17.65%	-21.53%	-21.3%
Other Assets
YoY Change
Total Long-Term Assets	$256.9M	$251.8M	$320.4M
YoY Change	-16.35%	-21.42%	-21.24%
TOTAL ASSETS
Total Short-Term Assets	$33.29M	$23.52M	$14.81M
Total Long-Term Assets	$256.9M	$251.8M	$320.4M
Total Assets	$290.2M	$275.3M	$335.2M
YoY Change	-18.09%	-17.88%	-21.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.023M	$987.8K	$2.390M
YoY Change	-59.98%	-58.66%	48.75%
Accrued Expenses	$2.610M	$2.757M	$1.773M
YoY Change	4.52%	55.49%	2.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.633M	$3.818M	$4.163M
YoY Change	-28.11%	-8.3%	24.83%
LONG-TERM LIABILITIES
Long-Term Debt	$123.3M	$123.1M	$186.6M
YoY Change	-34.0%	-34.0%	0.51%
Other Long-Term Liabilities	$10.85M	$3.998M	$4.658M
YoY Change		-14.17%	-5.43%
Total Long-Term Liabilities	$134.1M	$127.1M	$191.2M
YoY Change	-28.19%	-33.51%	0.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.633M	$3.818M	$4.163M
Total Long-Term Liabilities	$134.1M	$127.1M	$191.2M
Total Liabilities	$137.8M	$130.9M	$195.4M
YoY Change	-28.19%	-32.98%	0.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$316.6M	-$315.4M
YoY Change
Common Stock	$627.1K	$596.7K	$498.9K
YoY Change	11.19%	19.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$152.4M	$144.3M	$139.8M
YoY Change
Total Liabilities & Shareholders Equity	$290.2M	$275.3M	$335.2M
YoY Change	-18.09%	-17.88%	-21.16%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$5.259M	-$1.768M	$6.268M
YoY Change	-54.61%	-128.21%	-176.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$6.367M	$20.29M	$6.845M
YoY Change	-70.08%	196.47%	-38.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.741M	-$5.128M	-$5.101M
YoY Change	-75.05%	0.52%	0.15%
NET CHANGE
Cash From Operating Activities	6.367M	$20.29M	$6.845M
Cash From Investing Activities
Cash From Financing Activities	2.741M	-$5.128M	-$5.101M
Net Change In Cash	9.108M	$15.17M	$1.744M
YoY Change	-71.77%	769.62%	-71.21%
FREE CASH FLOW
Cash From Operating Activities	$6.367M	$20.29M	$6.845M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	oxsq	Underwriting Fees And Offering Costs For The Issuance Of Common Stock UnderwritingFeesAndOfferingCostsForTheIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49858366	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59653180	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Entity File Number EntityFileNumber	814-00638
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8 SOUND SHORE DRIVE
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 255
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	GREENWICH
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06830
CY2024Q1	dei	City Area Code CityAreaCode	(203)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	983-5275
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59721449	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20906690	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5740553	usd
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	2615160	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3976408	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	910124	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1060384	usd
CY2024Q1	us-gaap	Assets Assets	275288020	usd
CY2023Q4	us-gaap	Assets Assets	277667772	usd
CY2024Q1	us-gaap	Securities Loaned SecuritiesLoaned	3997500	usd
CY2024Q1	oxsq	Base Fee And Net Investment Income Incentive Fee Payable To Affiliate BaseFeeAndNetInvestmentIncomeIncentiveFeePayableToAffiliate	987816	usd
CY2023Q4	oxsq	Base Fee And Net Investment Income Incentive Fee Payable To Affiliate BaseFeeAndNetInvestmentIncomeIncentiveFeePayableToAffiliate	1012389	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1204487	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1204487	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1552652	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1163349	usd
CY2024Q1	us-gaap	Distribution Payable DistributionPayable	72568	usd
CY2024Q1	us-gaap	Liabilities Liabilities	130948197	usd
CY2023Q4	us-gaap	Liabilities Liabilities	126359147	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59672337	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59672337	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59300472	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59300472	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	596723	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	593005	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	459180359	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	458121381	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-315437259	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-307405761	usd
CY2024Q1	us-gaap	Assets Net AssetsNet	-144339823	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	-151308625	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	275288020	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277667772	usd
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.42
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.55
CY2024Q1	us-gaap	Interest Income Operating Paid In Cash InterestIncomeOperatingPaidInCash	10677424	usd
CY2023Q1	us-gaap	Interest Income Operating Paid In Cash InterestIncomeOperatingPaidInCash	12941798	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1960982	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3085366	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	987816	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1159646	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	311747	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	335880	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	206898	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	266965	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	346625	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	373173	usd
CY2024Q1	oxsq	Total Expenses Before Incentive Fees TotalExpensesBeforeIncentiveFees	3814068	usd
CY2023Q1	oxsq	Total Expenses Before Incentive Fees TotalExpensesBeforeIncentiveFees	5221030	usd
CY2023Q1	oxsq	Net Investment Income Incentive Fees NetInvestmentIncomeIncentiveFees	1229984	usd
CY2023Q1	oxsq	Incentive Fees IncentiveFees	1229984	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3814068	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6451014	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	232621	usd
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	13572	usd
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	8101869	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	3525000	usd
CY2024Q1	oxsq	Repayment Of Principal Securities Investments RepaymentOfPrincipalSecuritiesInvestments	17914419	usd
CY2023Q1	oxsq	Repayment Of Principal Securities Investments RepaymentOfPrincipalSecuritiesInvestments	318680	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1390625	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8094940	usd
CY2024Q1	oxsq	Net Investment Income Before Taxes NetInvestmentIncomeBeforeTaxes	6863356	usd
CY2023Q1	oxsq	Net Investment Income Before Taxes NetInvestmentIncomeBeforeTaxes	6490784	usd
CY2024Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	325800	usd
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	6537556	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	6490784	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-211006	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-222301	usd
CY2024Q1	oxsq	Non Affiliated Non Control Investments NonAffiliatedNonControlInvestments	8094940	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8094940	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1768390	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6268483	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.13
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59639285	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49858366	shares
CY2024Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.105
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.105
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	6537556	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	6490784	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-211006	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-222301	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-8094940	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1768390	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6268483	usd
CY2024Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	6263108	usd
CY2023Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	5235080	usd
CY2024Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-6263108	usd
CY2023Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-5235080	usd
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9493	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	923460	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	139236	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	133783	usd
CY2024Q1	oxsq	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	1062696	usd
CY2023Q1	oxsq	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	133783	usd
CY2024Q1	oxsq	Increasedecrease In Net Assets Total IncreasedecreaseInNetAssetsTotal	-6968802	usd
CY2023Q1	oxsq	Increasedecrease In Net Assets Total IncreasedecreaseInNetAssetsTotal	1167186	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	151308625	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	138671962	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	144339823	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	139839148	usd
CY2024Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	324122	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	47743	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	41158	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	371865	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	41158	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1768390	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6268483	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	302275	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	340019	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	154252	usd
CY2024Q1	oxsq	Reductions To Clo Equity Cost Value ReductionsToCLOEquityCostValue	838607	usd
CY2023Q1	oxsq	Reductions To Clo Equity Cost Value ReductionsToCLOEquityCostValue	3009028	usd
CY2024Q1	us-gaap	Restricted Investments Percent Of Net Assets RestrictedInvestmentsPercentOfNetAssets	0.02	pure
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-211006	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-222301	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1361248	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	555237	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-150260	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-49265	usd
CY2024Q1	oxsq	Increase Decrease In Base Fee And Net Investment Income Incentive Fee Payable IncreaseDecreaseInBaseFeeAndNetInvestmentIncomeIncentiveFeePayable	24573	usd
CY2023Q1	oxsq	Increase Decrease In Base Fee And Net Investment Income Incentive Fee Payable IncreaseDecreaseInBaseFeeAndNetInvestmentIncomeIncentiveFeePayable	-1066057	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	389303	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	99121	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20293981	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6845300	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	139236	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	133783	usd
CY2024Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	72568	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6051304	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5101297	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	932953	usd
CY2024Q1	oxsq	Underwriting Fees And Offering Costs For The Issuance Of Common Stock UnderwritingFeesAndOfferingCostsForTheIssuanceOfCommonStock	9493	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5127844	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5101297	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15166137	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1744003	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5740553	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9019164	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20906690	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10763167	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	139236	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	133783	usd
CY2024Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	72568	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1806730	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2852747	usd
CY2024Q1	us-gaap	Payments For Securities Purchased Under Agreements To Resell PaymentsForSecuritiesPurchasedUnderAgreementsToResell	3997500	usd
CY2023Q1	us-gaap	Payments For Securities Purchased Under Agreements To Resell PaymentsForSecuritiesPurchasedUnderAgreementsToResell	4657500	usd
CY2024Q1	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">INVESTMENT INCOME</span></p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Interest Income</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Interest income is recorded on an accrual basis using the contractual rate applicable to each debt investment and includes the accretion of market discounts and/or original issue discount (“OID”) and amortization of market premiums. Discounts from and premiums to par value on securities purchased are accreted/amortized into interest income over the life of the respective security using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums, if any.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Generally, when interest and/or principal payments on a loan become past due, or if the Company otherwise does not expect the borrower to be able to service its debt and other obligations, the Company will place the loan on non<span class="nobreak">-accrual</span> status and will generally cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Company generally restores non<span class="nobreak">-accrual</span> loans to accrual status when past due principal and interest is paid and, in the Company’s judgment, is likely to remain current. As of March 31, 2024, the Company had six debt investments in three portfolio companies that were on non<span class="nobreak">-accrual</span> status. As of December 31, 2023, the Company had four debt investments in two portfolio companies that were on non<span class="nobreak">-accrual</span> status.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Interest income also includes a payment<span class="nobreak">-in-kind</span> (“PIK”) component on certain investments in the Company’s portfolio. Refer to the section below, “Payment<span class="nobreak">-In-Kind</span>,” for a description of PIK income and its impact on interest income.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Payment-In-Kind</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company has debt and preferred stock investments in its portfolio that contain contractual PIK provisions. PIK interest and preferred stock dividends are computed at their contractual rates and are accrued into income and recorded as interest and dividend income, respectively. The PIK amounts are added to the principal balances on the capitalization dates. Upon capitalization, the PIK portions of the investments are valued at their respective fair values. If the Company believes that a PIK is not fully expected to be realized, the PIK investment would be placed on non<span class="nobreak">-accrual</span> status. When a PIK investment is placed on non<span class="nobreak">-accrual</span> status, the accrued, uncapitalized interest or dividends would be reversed from the related receivable through interest or dividend income, respectively. </p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:8pt;">PIK investments on non<span class="nobreak">-accrual</span> status are restored to accrual status once it becomes probable that such PIK will be ultimately collectible in cash. For the three months ended March 31, 2024, approximately $14,000 of PIK was recognized as interest income. For the three months ended March 31, 2023, no PIK interest was recognized as interest income. For the three months ended March 31, 2024 and 2023, the Company did not recognize PIK dividend income on its preferred stock investments.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income from Securitization Vehicles and Investments</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Income from investments in the equity class securities of CLO vehicles (typically income notes or subordinated notes) is recorded using the effective interest method in accordance with the provisions of ASC 325<span class="nobreak">-40</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Beneficial Interests in Securitized Financial Assets</span>, based upon estimated cash flows, amounts and timing, including those CLO equity investments that have not made their inaugural distribution for the relevant period end. We monitor the expected residual payments, and effective yield is determined and updated periodically, as needed. Accordingly, investment income recognized on CLO equity securities in the statements of operations differs from both the tax<span class="nobreak">-basis</span> investment income and from the cash distributions actually received by the Company during the period.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company also records income on its investments in CLO warehouse facilities based on a stated rate per the underlying note purchase agreement plus accrued interest or, if there is no stated rate, then an estimated rate is calculated using a base case model projecting the timing of the ramp<span class="nobreak">-up</span> of the CLO warehouse facility. For the three months ended March 31, 2024 and 2023, no income was recognized related to CLO warehouse facilities. As of March 31, 2024 and December<span class="nobreak"> </span>31, 2023, the Company did not hold any investments in CLO warehouse facilities.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other Income</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Other income includes prepayment, amendment, and other fees earned by the Company’s loan investments, distributions from fee letters and success fees associated with portfolio investments. Distributions from fee letters are an enhancement to the return on a CLO equity investment and are based upon a percentage of the collateral manager’s fees above the amortized cost, and are recorded as other income when earned. The Company may also earn success fees associated with its investments in certain securitization vehicles or CLO warehouse facilities, which are contingent upon a repayment of the warehouse by a permanent CLO securitization structure; such fees are earned and recognized when the repayment is completed.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Preferred Stock Dividends</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The Company holds preferred stock investments in its portfolio that contain cumulative preferred dividends that accumulate quarterly. The Company will generally record cumulative preferred dividends as investment income when they are received or declared by the portfolio company’s board of directors or upon any voluntary or involuntary liquidation, dissolution or winding up of the portfolio company, and are collectible. There were no cumulative preferred dividends recorded as dividend income during the three months ended March 31, 2024 and 2023, as the Company deemed them to be uncollectible.</p>
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	14000	usd
CY2024Q1	oxsq	Net Unrealizeddepreciationappreciation Included In Earnings NetUnrealizeddepreciationappreciationIncludedInEarnings	-0.2	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">USE OF ESTIMATES</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The financial statements have been prepared in accordance with GAAP, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates, and these differences could be material.</p>
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-8.1	usd
CY2024Q1	oxsq	Distribution Of Investment Percentage DistributionOfInvestmentPercentage	0.90	pure
CY2024Q1	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	464982380	usd
CY2023Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	479922143	usd
CY2024Q1	oxsq	Unamortized Deferred Debt Issuance Costs UnamortizedDeferredDebtIssuanceCosts	0.055	pure
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	266.9	usd
CY2024Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscount	0.3	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	12.1	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-19.3	usd
CY2024Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reduction Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionEquityCostValue	-0.8	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	250.9	usd
CY2024Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedDepreciation	-8.4	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	314.7	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-17.1	usd
CY2023	oxsq	Net Unrealizeddepreciationappreciation Included In Earnings NetUnrealizeddepreciationappreciationIncludedInEarnings	7.1	usd
CY2023	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscount	1.1	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	11.7	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-35.4	usd
CY2023	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reduction Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionEquityCostValue	-15.3	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	266.9	usd
CY2023	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Depreciation FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedDepreciation	-12.1	usd
CY2024Q1	oxsq	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reductions Equity Cost Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReductionsEquityCostValue	15300000	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	32000000	usd
CY2024Q1	oxsq	Cost Basis Amortization Of Fee Letter Investments CostBasisAmortizationOfFeeLetterInvestments	123000	usd
CY2024Q1	oxsq	Income From Securitization Vehicles And Investment IncomeFromSecuritizationVehiclesAndInvestment	16800000	usd
CY2024Q1	us-gaap	Cash Cash	678912	usd
CY2023Q4	us-gaap	Cash Cash	1160664	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20227778	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4579889	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20906690	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5740553	usd
CY2024Q1	oxsq	Least Borrowing Percentage LeastBorrowingPercentage	1.50	pure
CY2024Q1	oxsq	Asset Coverage Percentage AssetCoveragePercentage	2.13	pure
CY2023Q4	oxsq	Asset Coverage Percentage AssetCoveragePercentage	2.19	pure
CY2024Q1	oxsq	Unsecured Repaid Percentage UnsecuredRepaidPercentage	0.0625	pure
CY2024Q1	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P3Y6M
CY2023	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P3Y9M18D
CY2024Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	485000	usd
CY2024Q1	us-gaap	Percentage Of Unamortized Film Costs PercentageOfUnamortizedFilmCosts	0.0625	pure
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	1000000	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	1000000	usd
CY2024Q1	oxsq	Pre Incentive Fee Hurdle Rate PreIncentiveFeeHurdleRate	0.0884	pure
CY2023	oxsq	Pre Incentive Fee Hurdle Rate PreIncentiveFeeHurdleRate	0.0899	pure
CY2024Q1	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.02	pure
CY2024Q1	oxsq	Preferred Return Amount Percentage PreferredReturnAmountPercentage	0.0175	pure
CY2024Q1	oxsq	Catchup Amount Percentage CatchupAmountPercentage	0.021875	pure
CY2024Q1	oxsq	Pre Incentive Fee Net Investment Income Maximum Percentage PreIncentiveFeeNetInvestmentIncomeMaximumPercentage	0.20	pure
CY2024Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	207000	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	267000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	6537556	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	6490784	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59639285	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49858366	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1768390	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6268483	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.13
CY2024Q1	oxsq	Percentage Of Distribute Minimum Annual Investment Company Taxable Income PercentageOfDistributeMinimumAnnualInvestmentCompanyTaxableIncome	0.90	pure
CY2024Q1	oxsq	Excise Tax Percentage ExciseTaxPercentage	0.04	pure
CY2024Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	47743	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	41158	shares
CY2024Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	2100000	usd
CY2024Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	2100000	usd
CY2024Q1	us-gaap	Interest And Dividends Payable Current And Noncurrent InterestAndDividendsPayableCurrentAndNoncurrent	2100000	usd
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.035
CY2024Q1	us-gaap	Partners Capital Distribution Amount Per Share PartnersCapitalDistributionAmountPerShare	0.105
CY2023Q3	oxsq	Current Capacity Of Share Issuances CurrentCapacityOfShareIssuances	150000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	324122	shares
CY2024Q1	oxsq	Underwriting Fees And Offering Costs UnderwritingFeesAndOfferingCosts	923000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	6142029	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	7945032	usd
CY2024Q1	oxsq	Original Issue Discount And Market Discount Income OriginalIssueDiscountAndMarketDiscountIncome	302275	usd
CY2023Q1	oxsq	Original Issue Discount And Market Discount Income OriginalIssueDiscountAndMarketDiscountIncome	340019	usd
CY2024Q1	oxsq	Discount Income Derived From Unscheduled Remittances At Par DiscountIncomeDerivedFromUnscheduledRemittancesAtPar	-23257	usd
CY2023Q1	oxsq	Discount Income Derived From Unscheduled Remittances At Par DiscountIncomeDerivedFromUnscheduledRemittancesAtPar	9109	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6421047	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8294160	usd
CY2024Q1	us-gaap	Interest And Fee Income Loans Consumer Installment Automobiles Marine And Other Vehicles InterestAndFeeIncomeLoansConsumerInstallmentAutomobilesMarineAndOtherVehicles	3932374	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans Consumer Installment Automobiles Marine And Other Vehicles InterestAndFeeIncomeLoansConsumerInstallmentAutomobilesMarineAndOtherVehicles	4379495	usd
CY2024Q1	oxsq	Fee Letters FeeLetters	131988	usd
CY2023Q1	oxsq	Fee Letters FeeLetters	155078	usd
CY2024Q1	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	192015	usd
CY2023Q1	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	113065	usd
CY2024Q1	us-gaap	Other Income OtherIncome	324003	usd
CY2023Q1	us-gaap	Other Income OtherIncome	268143	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	10677424	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	12941798	usd
CY2024Q1	us-gaap	Investment Company Total Return Before Incentive Fees InvestmentCompanyTotalReturnBeforeIncentiveFees	0.1117	pure
CY2023Q1	us-gaap	Investment Company Total Return Before Incentive Fees InvestmentCompanyTotalReturnBeforeIncentiveFees	0.15	pure
CY2023Q1	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees	0.0353	pure
CY2024Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0588	pure
CY2023Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0967	pure
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned		usd
CY2023Q4	us-gaap	Distribution Payable DistributionPayable		usd
CY2024Q1	oxsq	Net Investment Income Incentive Fees NetInvestmentIncomeIncentiveFees		usd
CY2024Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense		usd
CY2024Q1	oxsq	Incentive Fees IncentiveFees		usd
CY2023Q1	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes		usd
CY2023Q1	oxsq	Non Affiliated Non Control Investments NonAffiliatedNonControlInvestments		usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction		shares
CY2023Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q1	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution		usd
CY2023Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2024Q1	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023Q1	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001259429

Files In Submission

Name	View Source	Status
0001213900-24-039266-index-headers.html	Edgar Link	pending
0001213900-24-039266-index.html	Edgar Link	pending
0001213900-24-039266.txt	Edgar Link	pending
0001213900-24-039266-xbrl.zip	Edgar Link	pending
ea0204324-01_10q.htm	Edgar Link	pending
ea0204324-01_ex311.htm	Edgar Link	pending
ea0204324-01_ex312.htm	Edgar Link	pending
ea0204324-01_ex321.htm	Edgar Link	pending
ea0204324-01_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oxsq-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
oxsq-20240331_cal.xml	Edgar Link	unprocessable
oxsq-20240331_def.xml	Edgar Link	unprocessable
oxsq-20240331_lab.xml	Edgar Link	unprocessable
oxsq-20240331_pre.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ea0204324-01_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OXSQ
Oxford Square Capital Corp. Stock $oxsq

2024 Q2 Form 10-Q Financial Statement

#000121390024039266 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXSQ Oxford Square Capital Corp. Stock $oxsq

2024 Q2 Form 10-Q Financial Statement

#000121390024039266 Filed on May 03, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OXSQ
Oxford Square Capital Corp. Stock $oxsq